PT 592 - Fayzan Rab - Emory University

Psychedelics Today

In this episode, Joe interviews Fayzan Rab, an MD candidate (when we recorded) at Emory University with a background in tech at Google and a focus on the intersection of psychedelics, spirituality, and public health. Fayzan shares Emory's unique approach to psychedelic studies, emphasizing spiritual health and the lived religious and existential aspects of psychedelic experiences—what he and his team call "CERT."

The conversation explores Fayzan's collaboration with health economist Elliot Marseille on economic modeling for psilocybin therapy, including their estimate that over 5 million Americans could be medically eligible. He shares insights into the policy challenges around payer systems and the importance of preparing implementation strategies before FDA approval.

Fayzan also discusses his groundbreaking research on Muslim perspectives on psychedelics—revealing surprising openness, complex spiritual tensions, and a strong interest in integrating these substances into healing and faith-based frameworks. He highlights the need for inclusive infrastructure and upcoming work with clergy to deepen the conversation.

Finally, they explore non-clinical psychedelic use among healthcare workers and entrepreneurs, discussing how psychedelics are being used to address burnout, identity, and life purpose.

This is a powerful episode about interdisciplinary collaboration, cultural sensitivity, and the potential for psychedelics to transform not just individuals—but systems.

Links

Science on Spiritual Health Symposium 2025

Center for Psychedelics and Spirituality - Emory University

More description

In this episode, Joe interviews Fayzan Rab, an MD candidate (when we recorded) at Emory University with a background in tech at Google and a focus on the intersection of psychedelics, spirituality, and public health. Fayzan shares Emory's unique approach to psychedelic studies, emphasizing spiritual health and the lived religious and existential aspects of psychedelic experiences—what he and his team call "CERT."

The conversation explores Fayzan's collaboration with health economist Elliot Marseille on economic modeling for psilocybin therapy, including their estimate that over 5 million Americans could be medically eligible. He shares insights into the policy challenges around payer systems and the importance of preparing implementation strategies before FDA approval.

Fayzan also discusses his groundbreaking research on Muslim perspectives on psychedelics—revealing surprising openness, complex spiritual tensions, and a strong interest in integrating these substances into healing and faith-based frameworks. He highlights the need for inclusive infrastructure and upcoming work with clergy to deepen the conversation.

Finally, they explore non-clinical psychedelic use among healthcare workers and entrepreneurs, discussing how psychedelics are being used to address burnout, identity, and life purpose.

This is a powerful episode about interdisciplinary collaboration, cultural sensitivity, and the potential for psychedelics to transform not just individuals—but systems.

Links

Science on Spiritual Health Symposium 2025

Center for Psychedelics and Spirituality - Emory University

2025-04-01 80 min
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in

Chapters

No chapters available.